Hypertension
Bedtime dosing of antihypertensive medications: systematic review and consensus statement. – “use of bedtime drug dosing of antihypertensive drugs should not be routinely recommended”.
29 Aug, 2022 | 12:28h | UTC
RCT | Self-measurement of blood pressure with a standard device is not enhanced by the use of a connected smartphone application.
26 Aug, 2022 | 13:29h | UTCEffectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application: A Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)
News Release: For Checking Blood Pressure at Home, Basic Cuffs Are Just as Good – UC San Francisco
Commentary: App-enabled device no better than standard device for self-measuring blood pressure – ACP Internist
Commentary on Twitter
Monitoring #bloodpressure at home may help with #bloodpressurecontrol, but using an enhanced device pairing with a smartphone application appears to be no more effective than using a standard device. https://t.co/h6zREImCNv #Research pic.twitter.com/T1zWDlp2pC
— JAMA Internal Medicine (@JAMAInternalMed) August 15, 2022
Cross-Sectional Study | Hypertension common among poorest, least educated around the world.
22 Aug, 2022 | 12:14h | UTCThe Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income Countries – Journal of the American College of Cardiology (link to abstract – $ for full-text)
News Release: Hypertension Common Among Poorest, Least Educated Around the World – American College of Cardiology
Commentary: Hypertension Common Among Poorest, Least Educated Globally – HealthDay
Commentary on Twitter
#HTN is a common condition in low- & middle-income countries. As countries develop economically, these groups may experience a greater #hypertension prevalence relative to those w/ ⬆️ socioeconomic status. Read more on this important work now out in #JACC: https://t.co/sOzb1aWRvk pic.twitter.com/w00raCmuCW
— JACC Journals (@JACCJournals) August 16, 2022
Cohort Study | Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease.
19 Aug, 2022 | 16:09h | UTCOriginal Study: Aldosterone in chronic kidney disease and renal outcomes – European Heart Journal
Editorial: Aldosterone excess and cardiorenal risk: more common than appreciated – European Heart Journal
Commentary on Twitter
Aldosterone in chronic kidney disease and renal outcomes https://t.co/G8FA4H5QX4 #EHJ #ESCYoung @ehj_ed @rladeiraslopes @escardio pic.twitter.com/D48MeAeSR1
— European Society of Cardiology Journals (@ESC_Journals) August 9, 2022
M-A | Performance of confirmatory tests for diagnosing primary aldosteronism.
18 Aug, 2022 | 12:54h | UTC
Commentary on Twitter
Less than 1% of patients suffering from PA are treated. Current strategies for diagnosing PA don't work well. Simplify testing for better diagnosis and treatment #hypertension #PrimaryAldosteronism @dr_alexleung @JanicePasieka @IAESurgeonshttps://t.co/AKkyUfSLoG pic.twitter.com/HcLQTdB2ao
— Hypertension (@HyperAHA) August 16, 2022
Modeling Study | Reducing daily salt intake in China by 1 g could prevent almost 9 million cardiovascular events by 2030.
18 Aug, 2022 | 12:42h | UTCNews Release: 1 g cut in daily salt intake could ward off nearly 9 million cases of stroke/heart disease in China – BMJ Newsroom
Harmonization of American and European hypertension guidelines: comparisons, reflections, and recommendations.
12 Aug, 2022 | 15:19h | UTCHarmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations – European Heart Journal (also available at Circulation)
Systematic Review | Replacing salt with low‐sodium salt substitutes for cardiovascular health in adults, children and pregnant women.
10 Aug, 2022 | 15:38h | UTCRelated:
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
M-A | Effects of salt substitutes on clinical outcomes.
10 Aug, 2022 | 15:40h | UTCEffects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart
Commentary: Swapping salt for substitutes reduces risk of stroke and heart conditions – study – The Guardian
Related:
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Commentary from the author on Twitter
Our latest meta-analysis shows consistent effects of salt substitutes on BP across diverse geographies and populations. Protective effects on clinical outcomes are likely to be generalizable to countries worldwide. https://t.co/C273yK6Bek
— Xuejun Yin (@XuejunYin) August 10, 2022
M-A | Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes.
29 Jul, 2022 | 12:37h | UTCCommentaries:
No justification for bespoke antihypertensive intervention in type 2 diabetes – medwire News
Blood pressure control according to type 2 diabetes status – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
Online—Blood pressure-lowering treatment for prevention of major #cardiovascular diseases in people with and without type 2 #diabetes: an individual participant-level data meta-analysis https://t.co/AmNxyW9Via #T2D #BloodPressure #hypertension #openaccess pic.twitter.com/NfdLktZXai
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 25, 2022
Systematic Review | Antiplatelet agents and anticoagulants for hypertension.
29 Jul, 2022 | 12:29h | UTCAntiplatelet agents and anticoagulants for hypertension – Cochrane Library
Summary: Antiplatelet agents and anticoagulants for high blood pressure – Cochrane Library
Commentary on Twitter
Do #antiplatelet agents & #anticoagulants improve outcomes in people with #hypertension?
Our newly updated @CochraneLibrary review looks at the evidence of 6 RCTs involving more than 61,000 participants: https://t.co/zaXP4YLg4n#CochraneEvidence #blogshot pic.twitter.com/X1DK2NTCtb
— Cochrane Hypertension (@CochraneHTN) July 28, 2022
Practical Guide | Antihypertensive deprescribing in older adults.
27 Jul, 2022 | 12:23h | UTCAntihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports
Cohort Study | Markers of focal and diffuse nonischemic myocardial fibrosis are associated with adverse cardiac remodeling and prognosis in patients with hypertension.
26 Jul, 2022 | 11:46h | UTCCommentary: Heart muscle scarring found in patients with hypertension are associated with worse outcomes – SingHealth
Cross Sectional Study | Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US.
19 Jul, 2022 | 13:08h | UTCCommentaries:
12 Risk Factors Linked to Dementia Could Be Modified, Reduce US Cases by 400,000 – HCP Live
Hypertension, obesity, physical inactivity among highest risk factors for dementia – Healio
Commentary on Twitter
Number of people w/dementia is growing worldwide; this article identifies 12 modifiable risk factors accounting for~ 40% of people w/dementia. Hypertension most imp, followed by obesity and physical inactivity. https://t.co/mD5lrqZTyf @JAMANetworkOpen Kudos @PLutsey & team. pic.twitter.com/LG5LjFHqV6
— Harlan Krumholz (@hmkyale) July 7, 2022
In this cross-sectional study, a large fraction of dementia cases in the US were associated with potentially modifiable risk factors, especially for Black and Hispanic individuals. https://t.co/v6g2HPNLpR
— JAMA Network Open (@JAMANetworkOpen) July 6, 2022
RCT | Effects of cuisine-based Chinese heart-healthy diet in lowering blood pressure among adults in China.
13 Jul, 2022 | 11:29h | UTCNews Release: Heart-healthy, lower sodium version of traditional Chinese cuisine lowered blood pressure – American Heart Association
Commentary: Modified Chinese Food Diet Lowers BP in Hypertensive Adults – HealthDay
Cohort Study | Adding salt to foods and hazard of premature mortality.
11 Jul, 2022 | 12:35h | UTCAdding salt to foods and hazard of premature mortality – European Heart Journal (free for a limited period)
Editorial: Salt: the sweet spot?
M-A | Associations of thiazide use with skin cancers.
8 Jul, 2022 | 11:55h | UTCAssociations of thiazide use with skin cancers: a systematic review and meta-analysis – BMC Medicine
Related:
Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma – JAMA Internal Medicine
Podcast | Hypertension FAQ and cardiorenal syndrome.
6 Jul, 2022 | 11:28h | UTC#343 Hypertension FAQ and Cardiorenal: A rapid review (TFTC) – The Curbsiders
Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope.
5 Jul, 2022 | 12:18h | UTC
Commentary on Twitter
Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study.https://t.co/tMlGHQ4Csm#hypotension #bloodpressure #cardiotwitter @ESC_Journals @escardio pic.twitter.com/JpX6kxwj1R
— EHJ Editor-in-Chief (@ehj_ed) July 2, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
An update on refractory hypertension.
24 Jun, 2022 | 11:44h | UTCAn Update on Refractory Hypertension – Current Hypertension Reports
Review, Statements, and Recommendations: Cuffless blood pressure measuring devices.
20 Jun, 2022 | 01:26h | UTCRelated:
AHA Scientific Statement: Revascularization for renovascular disease.
17 Jun, 2022 | 11:50h | UTCTop Things to Know: Revascularization for Renovascular Disease – American Heart Association
Commentary: When is Renovascular Hypertension Amenable to Revascularization – American Heart Association